Concepedia

Chuanpu Hu

CH

32

Publications

1.4K

Citations

21

H-Index

1996

Active since

Affiliations

Janssen (United States)(Current)

Springhouse

Center for Drug Evaluation and Research

Pfizer (United States)

Janssen (Belgium)

Chuanpu Hu is an author at Janssen (United States) specializing in medicine, pharmacotherapy, and pharmacology.

ORCID

Top concepts

Publications per year

1996–2020

32

Publications

32

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis

Adedigbo A. Fasanmade, Omoniyi J. Adedokun, Joyce Ford et al. · European Journal of Clinical Pharmacology · 2009 · 319 citations · Full text

Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL‐12/23p40, in Patients With Moderate to Severe Plaque Psoriasis

Yaowei Zhu, Chuanpu Hu, Ming Lu et al. · The Journal of Clinical Pharmacology · 2009 · 166 citations

, , +13

A Joint Model for Nonlinear Longitudinal Data with Informative Dropout

Chuanpu Hu, Mark Sale · Journal of Pharmacokinetics and Pharmacodynamics · 2003 · 104 citations

, , +6

Population Pharmacokinetics of Golimumab, an Anti‐Tumor Necrosis Factor‐α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis

Zhenhua Xu, Thuy Vu, Howard Lee et al. · The Journal of Clinical Pharmacology · 2009 · 90 citations

Population‐Based Exposure‐Efficacy Modeling of Ustekinumab in Patients With Moderate to Severe Plaque Psoriasis

Honghui Zhou, Chuanpu Hu, Yaowei Zhu et al. · The Journal of Clinical Pharmacology · 2009 · 59 citations

, , +16

Rows per page

1–5 of 32